TAG ARCHIVE

POSTS TAGGED AS genomics

Semi-Conductor Based Sequencing

September 5, 2011 | Terry Sharrer | Posted in Newsletter

Earlier this year, Tagline carried a story about “desktop sequencing” based on Ion Torrent’s semi-conductor approach which detects DNA [MORE]

Fox Chase’s Cancer Genome Institute

July 19, 2011 | Terry Sharrer | Posted in Newsletter

Life Technologies, Inc. (Carlsbad, CA)-formed from a 2008 merger of Invitrogen Corporation and Applied Biosystems-has reached an agreement with [MORE]

Personal Genome Machine

May 24, 2011 | Terry Sharrer | Posted in Newsletter

Recently, Ion Torrent (Guilford, CT, a branch of Life Technologies-formerly Applied Biosciences) named Ambry Genetics (Aliso Viego, CA) as [MORE]

Testing Breast Cancer Tests

May 17, 2011 | Terry Sharrer | Posted in Newsletter

In 1955, the National Cancer Institute began organizing oncologists into regional study groups to address specific interests that NCI [MORE]

Social Network Analysis for Epidemiology

April 26, 2011 | Terry Sharrer | Posted in Newsletter

Suppose an outbreak of a new antibiotic- resistant pathogen appeared in one place and then another, and onward from [MORE]

Genomics Coaching, Colon Cancer

April 19, 2011 | Terry Sharrer | Posted in Newsletter

A rap against consumer genomics has been the lack of interpreting authority-e.g. what does a 30% increase in risk [MORE]

A Catch-22 for Cancer Survivors

April 12, 2011 | Terry Sharrer | Posted in Newsletter

Surviving cancer can have adverse effects-e.g. cardiovascular complications, obesity, diabetes, osteopenia and osteoporosis, et al. For those reasons, cancer [MORE]

Screening by Sequencing

March 15, 2011 | Terry Sharrer | Posted in Newsletter

In January, Stephen Kingsmore, chief scientific officer for the National Human Genome Research Institute, reported that he and his [MORE]

Brookings Study on IT and Personalized Medicine

February 28, 2011 | Pamela Cipriano | Posted in Newsletter

It has happened before, and often: scientific discovery running ahead of medical practice and public policy, with consumer demand [MORE]

Scripps’ Study of Personal Genomics

February 22, 2011 | Terry Sharrer | Posted in Newsletter

Last year, an FDA report about the superficiality of personalized genomics tests forestalled drug stores selling those kits. Two [MORE]

Problems in Stem Cell Genetics

February 22, 2011 | Terry Sharrer | Posted in Newsletter

Researchers at the University of California, San Diego and the Scripps Research Institute recently made a disturbing discovery [MORE]

Oncotype DX Soaring

February 8, 2011 | Terry Sharrer | Posted in Newsletter

Oncotype DX is a “companion diagnostic” for women with early stage breast cancer who might be treated with hormone [MORE]

Rapid DNA-Based Test for TB

January 18, 2011 | Terry Sharrer | Posted in Newsletter

In poor countries, where tuberculosis ravages, the standard technique for detection is a sputum slide under a microscope.  But [MORE]

Genomic Unknowns

January 4, 2011 | Terry Sharrer | Posted in Newsletter

Thoroughbred race horse breeders have long observed what they call the “grand sire” effect-where the immediate offspring of a [MORE]

Achieving the Promise of Genomic Medicine


It has been 10 years since the publication of the first draft of the sequence of the human genome. This [MORE]

DNA Synthesis-Benchtop Automation?

November 9, 2010 | Terry Sharrer | Posted in Newsletter

To read this interview with Daniel Gibson, a molecular biologist with the J. Craig Venter Institute (Rockville, MD and San [MORE]

Small Science

October 5, 2010 | Terry Sharrer | Posted in Newsletter

The breakthroughs in molecular medicine open new vistas for health, but before this translates into healthcare, astute physicians must [MORE]

Illumina’s Distributed Genomics Network

October 5, 2010 | Terry Sharrer | Posted in Newsletter

This past summer, life sciences instrument maker Illumina, Inc. (San Diego, CA) announced its founding of a collaboration [MORE]

Chromosomal Microarray Proposed as New Standard for Pediatric Testing

August 24, 2010 | Terry Sharrer | Posted in Newsletter

Most tests for genetic diseases seek a single mutation or observable chromosome abnormality.  Chromosomal microarrays, by comparison, reveal copy [MORE]

Basic Science Links

July 30, 2010 | Jane Fruchtnicht | Posted in Links,Resources

Affymetrix, Cell Therapy News, Genome…MORE